Dutch go first: pre-approval tastings of cultivated meat & seafood in the Netherlands
It is just announced that it will soon be possible to taste farmed meat and seafood in the Netherlands under controlled conditions. The Dutch government, in collaboration with cultured meat producers Meatable and Mosa Meat, and industry representative HollandBIO, has successfully developed a ‘code of practice’ that will allow tastings in controlled environments.
EU Regulation of Genome Editing in Plants not yet a law
A long-awaited draft regulation from the EU Commission’s DG Sante to deregulate the authorisation, risk assessment and labelling of a whole range of new genetically modified organisms (GMOs) has been published today by the College of the Commission. New Genomic Techniques (NGT) are introduced as an umbrella term for certain genetic engineering techniques that aim to modify DNA more precisely than "old" methods by targeting changes to pre-defined loci in the genome. The proposal creates two distinct pathways for NGT plants to be placed on the market. "Category 1 NGTs" are considered equivalent to conventionally bred plants and no longer require prior case-by-case risk assessment.
Dutch NLC has 20m in first close of new Health Impact Fund
Dutch venture builder NLC has announced a 20m first close for its new Health Impact Fund, from which it will invest in 40 startups, both new investments and follow-on. It’s targeting a final close of 100m later this year.
French Carthera closes 37.5m Series B financing round
Carthera, a Sorbonne spin-off and developer of an innovative ultrasound-based medical device for the treatment of a wide range of brain disorders, today announced the successful completion of its 37.5m ($40m) Series B financing round.
Donaldson Acquires Belgian Univercells Technologies for 138m
Donaldson Company, Inc. (NYSE: DCI), a heritage provider of innovative filtration products and solutions, announced the acquisition of Univercells Technologies (Belgium), a global provider of innovative biomanufacturing solutions for cell and gene therapy research, development and commercial manufacturing.
Gleamer raises 27m in Series B funding round
French AI-powered radiography diagnostics specialist Gleamer SAS has raises 27m in Series B round to expand its portfolio and accelerate its expansion.
Centogene and Lifera kick-off joint venture
Multi-omics diagnostics specialist Centogene NV has received 30m to form a joint venture with PIF-owned pharmaceutical company Lifera in Saudi-Arabia.
Astraveus SAS bags 16.5m in seed financing
French cell and gene therapy manufacturing specialist Astraveus SAS had raises 16.5m in seed money to advance its automated, microfluidic Cell and Gene Therapy manufacturing platform.
New BIOTECH insight newsletter out
Breaking news from biotechnology and the German stock market are in the focus of the new issue of BIOTECH Insight, the newsletter of Deutsche Börse AG.